Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 1;79(6):623-626.
doi: 10.1001/jamaneurol.2022.0723.

Addition of Vision Impairment to a Life-Course Model of Potentially Modifiable Dementia Risk Factors in the US

Affiliations

Addition of Vision Impairment to a Life-Course Model of Potentially Modifiable Dementia Risk Factors in the US

Joshua R Ehrlich et al. JAMA Neurol. .

Erratum in

  • Errors in the Text and Key Points.
    [No authors listed] [No authors listed] JAMA Neurol. 2022 Jun 1;79(6):634. doi: 10.1001/jamaneurol.2022.1557. JAMA Neurol. 2022. PMID: 35695887 Free PMC article. No abstract available.

Abstract

Importance: Dementia prevention is a high priority, given the large impact of dementia on the well-being of individuals and society. The number of older adults with dementia in the US and globally is projected to increase as a result of population aging and growth. Thus, it is vital to identify potentially modifiable dementia risk factors. Vision impairment has been identified as a risk factor for accelerated cognitive decline and incident dementia. An estimated 90% of vision impairment is preventable or has yet to be treated. Nevertheless, vision impairment has not been included in the dominant life-course models of dementia risk factors used to shape public health policy and research priorities.

Objective: To strengthen an existing model of potentially modifiable dementia risk factors through the inclusion of vision impairment and to estimate the contributions of those risk factors in the US population.

Design, setting, and participants: Population-based, cross-sectional study using data from the 2018 round of the Health and Retirement Study. Analyses were conducted from March 11 through September 24, 2021. The study population was a probability sample of US adults aged 50 years and older.

Exposures: Potentially modifiable dementia risk factors, including vision impairment.

Main outcomes and measures: The estimated population attributable fractions (PAFs) of dementia associated with vision impairment and other dementia risk factors were calculated. The PAF represents the number of cases of dementia that would potentially be prevented if a risk factor were eliminated.

Results: The probability sample from the Health and Retirement Study included 16 690 participants (weighted demographic characteristics: 54.0% female, 52.0% age ≥65, 10.6% Black, 80% White, and 9.2% identified as other [including American Indian or Alaska Native, Asian, and Hawiian Native or Pacific Islander, although specific data were not available]). The 12 dementia risk factors in the PAF model were associated with an estimated 62.4% of dementia cases in the US. The risk factor with the highest weighted PAF for dementia was hypertension (12.4%). The PAF of vision impairment was 1.8%, suggesting that more than 100 000 prevalent dementia cases in the US could potentially have been prevented through healthy vision.

Conclusions and relevance: Existing life-course models of potentially modifiable dementia risk factors may consider including vision impairment. Since a large majority of vision impairment can be treated with cost-effective but underused interventions, this may represent a viable target for future interventional research that aims to slow cognitive decline and prevent incident dementia.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Ehrlich reported receiving grants from the National Institutes of Health (NIH) during the conduct of the study. Dr Swenor reported receiving grants from the NIH during the conduct of the study. Dr Langa reported grants from the National Institute on Aging (NIA) of the NIH during the conduct of the study; grants from NIA/NIH and grants from Alzheimer’s Association outside the submitted work. No other disclosures were reported.

Similar articles

Cited by

References

    1. Plassman BL, Langa KM, Fisher GG, et al. . Prevalence of dementia in the United States: the Aging, Demographics, and Memory Study. Neuroepidemiology. 2007;29(1-2):125-132. doi:10.1159/000109998 - DOI - PMC - PubMed
    1. Alzheimer’s Association . 2020 Alzheimer’s disease facts and figures. Alzheimers Dement. 2020;15(3):321-387. - PubMed
    1. Jutkowitz E, Kane RL, Gaugler JE, MacLehose RF, Dowd B, Kuntz KM. Societal and family lifetime cost of dementia: implications for policy. J Am Geriatr Soc. 2017;65(10):2169-2175. doi:10.1111/jgs.15043 - DOI - PMC - PubMed
    1. Livingston G, Huntley J, Sommerlad A, et al. . Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10 248):413-446. doi:10.1016/S0140-6736(20)30367-6 - DOI - PMC - PubMed
    1. Kuźma E, Littlejohns TJ, Khawaja AP, Llewellyn DJ, Ukoumunne OC, Thiem U. Visual impairment, eye diseases, and dementia risk: a systematic review and meta-analysis. J Alzheimers Dis. 2021;83(3):1073-1087. doi:10.3233/JAD-210250 - DOI - PubMed

Publication types